In many ways, Medicare Part D reflects an unprecedented success story, coming in massively under budget, with low and stable monthly premium...
When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few different things.
Obviously, transparency is key.
That said, much has changed in the past 2 decades, and we have an obligation both to build on the aspects of Part D that work well and to ad...
I have long championed efforts to improve prescription drug access and affordability for Americans, and I welcome the opportunity to engage ...
We have to change that.
We have got to figure out how to strengthen Medicare.
Today, I am introducing legislation called the Lower Drug Costs for Families Act, and what it will do is penalize pharmaceutical companies f...
We need to identify avenues for lowering out-of-pocket costs, increasing competition, and promoting access to lifesaving innovation--and we ...
Congress took a critical step toward addressing these challenges nearly 20 years ago, when we voted to enact Medicare's prescription drug be...
Some of the most lifesaving medications remain out of reach for far too many working families and seniors.
many people do.
